Aim: To evaluate the possible neuroprotective effects of systemic administration of cyclosporin (cyclosporin A) after traumatic brain injury in rats. Materials And Methods: The modified Feeney method was used as a model of trauma in male Sprague Dawley rats. After the injury, 20 mg / kg of cyclosporin was administered intraperitoneally to a group of rats (n = 15). Twenty-four hours after injury, the individuals were sacrificed and brain samples were collected. The brain edema level was assessed by lipid peroxidation rate, wet dry weight method and histological evaluation by transmission electron microscopy. Results: The brain edema level and the rate of lipid peroxidation were significantly reduced in the rats receiving cyclosporin. Ultra...
Considerable evidence has shown that the immunosuppressant drug cyclosporin A (CsA) may have neuropr...
Background. The most important task of intensive care patients with traumatic brain injury is preven...
AIM: To evaluate the neuroprotective effects of deocanthal OC in a rat model of traumatic brain inju...
Mitochondrial dysfunction is thought to be a hallmark of traumatic brain injury (TBI) and plays a pi...
Pre- and post-injury Cyclosporin A (CsA) administration has shown neuroprotective properties by amel...
After the onset of brain ischemia, a series of events leads ultimately to the death of neurons. Many...
The immunosuppressant drug cyclosporin A (CsA) is considered to be inherently protective in conditio...
The authors evaluated and compared the metabolic effects of cyclosporin A in the rat brain during no...
The immunosuppressant cyclosporin A (CsA) has been shown to have neuroprotective action. The inhibit...
Cyclosporin A (CsA) an immunophilin, discovered in 1969 and approved in 1983 to be used as immunosup...
Systemic administration of cyclosporine A (CsA) in single daily doses provides a powerful protection...
Cyclosporine (CsA) is a major immunosuppressant after organ transplantation. To date, two controvers...
It has recently been shown that the immunosuppressant cyclosporin A (CsA) dramatically ameliorates t...
Background: To evaluate the efficacy and side-effects of cyclosporine-A (CsA) in improvement of cons...
International audienceThe effects of ischemia-reperfusion on opening of the mitochondrial permeabili...
Considerable evidence has shown that the immunosuppressant drug cyclosporin A (CsA) may have neuropr...
Background. The most important task of intensive care patients with traumatic brain injury is preven...
AIM: To evaluate the neuroprotective effects of deocanthal OC in a rat model of traumatic brain inju...
Mitochondrial dysfunction is thought to be a hallmark of traumatic brain injury (TBI) and plays a pi...
Pre- and post-injury Cyclosporin A (CsA) administration has shown neuroprotective properties by amel...
After the onset of brain ischemia, a series of events leads ultimately to the death of neurons. Many...
The immunosuppressant drug cyclosporin A (CsA) is considered to be inherently protective in conditio...
The authors evaluated and compared the metabolic effects of cyclosporin A in the rat brain during no...
The immunosuppressant cyclosporin A (CsA) has been shown to have neuroprotective action. The inhibit...
Cyclosporin A (CsA) an immunophilin, discovered in 1969 and approved in 1983 to be used as immunosup...
Systemic administration of cyclosporine A (CsA) in single daily doses provides a powerful protection...
Cyclosporine (CsA) is a major immunosuppressant after organ transplantation. To date, two controvers...
It has recently been shown that the immunosuppressant cyclosporin A (CsA) dramatically ameliorates t...
Background: To evaluate the efficacy and side-effects of cyclosporine-A (CsA) in improvement of cons...
International audienceThe effects of ischemia-reperfusion on opening of the mitochondrial permeabili...
Considerable evidence has shown that the immunosuppressant drug cyclosporin A (CsA) may have neuropr...
Background. The most important task of intensive care patients with traumatic brain injury is preven...
AIM: To evaluate the neuroprotective effects of deocanthal OC in a rat model of traumatic brain inju...